Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts

Medicine & Life Sciences

• combretastatin 100%
• Optical Imaging 59%
• Brain Neoplasms 50%
• Heterografts 48%
• Blood Vessels 17%
• Neoplasms 17%
• Perfusion 13%
• Combretum 10%
• fosbretabulin 9%
• bisbenzimide ethoxide trihydrochloride 8%
• Colchicine 6%
• Prodrugs 6%
• Tubulin 6%
• Polymerization 6%
• Biological Products 5%
• Tumor Biomarkers 5%
• Luciferases 5%
• Binding Sites 4%
• Light 4%
• Clinical Studies 4%
• Water 4%
• Clinical Trials 3%
• Animals 3%
• Therapeutics 1%